---
title: "BC: Q2 2026 delivered robust sales and EPS growth, prompting higher full-year guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294342580.md"
description: "Q2 2026 saw 8% sales growth and a 34% rise in adjusted EPS, with all segments outperforming expectations. Full-year guidance was raised for revenue, EPS, and free cash flow, supported by strong market share gains, operational efficiencies, and significant IEEPA refunds.Original document: Brunswick Corporation [BC] Slides Release — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T10:15:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294342580.md)
  - [en](https://longbridge.com/en/news/294342580.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294342580.md)
generator: "portal-rs"
---

# BC: Q2 2026 delivered robust sales and EPS growth, prompting higher full-year guidance

Q2 2026 saw 8% sales growth and a 34% rise in adjusted EPS, with all segments outperforming expectations. Full-year guidance was raised for revenue, EPS, and free cash flow, supported by strong market share gains, operational efficiencies, and significant IEEPA refunds.

Original document: Brunswick Corporation \[BC\] Slides Release — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BC.US](https://longbridge.com/en/quote/BC.US.md)
- [BC-C.US](https://longbridge.com/en/quote/BC-C.US.md)
- [BC-A.US](https://longbridge.com/en/quote/BC-A.US.md)
- [BC-B.US](https://longbridge.com/en/quote/BC-B.US.md)

## Related News & Research

- [Sea Ray parent Brunswick bets on AI navigation and new revenue streams to help stalling boat sales](https://longbridge.com/en/news/296225183.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)
- [DE: 3Q 2026 saw sales and profit growth, but FY 2026 guidance signals industry headwinds](https://longbridge.com/en/news/296475895.md)
- [GRVY: 2Q 2026 saw stable revenue, strong global growth, and a first-ever KRW 30bn interim dividend](https://longbridge.com/en/news/296137591.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**